Clinician/Researcher, Alcalá University, Spain
Dr. Salvador González is an accredited Full Professor at the Quality and Accreditation Evaluation National Agency (ANECA) and an Associate Professor in Medicine at Universidad de Alcalá, Madrid, Spain. He also serves as an advisor in the Dermatology Department at Hospital Ramón y Cajal, Madrid. Dr. González has a remarkable career in dermatology and medical research, having held prestigious academic and clinical positions worldwide. He has taught at renowned institutions such as Harvard Medical School, Memorial Sloan-Kettering Cancer Center, and Universidad de Alcalá. His dedication to advancing dermatology spans clinical practice, teaching, and groundbreaking research. He has been instrumental in photodynamic therapy (PDT), reflectance confocal microscopy, and skin cancer prevention. His expertise has earned him global recognition and a multitude of awards, making him a leading figure in dermatology.
Profile
Scopus
Education
Dr. Salvador González’s academic journey began at the Universidad de Málaga, Spain, where he earned his MD in 1982. His specialization in dermatology was pursued at the Dermatology Department of the same university from 1982 to 1985. He furthered his education with a Diploma in Public Health from the National Health Institute, Madrid, in 1986, and later obtained his Ph.D. in Medicine (Cellular Biology, with a focus on dermatology) from the University of Málaga in 1990. His advanced studies laid the groundwork for his extensive work in medical research and dermatology. Throughout his career, Dr. González has continually expanded his academic horizons through positions at prestigious institutions such as Harvard Medical School, Massachusetts General Hospital, and Memorial Sloan-Kettering Cancer Center, earning global recognition for his expertise in dermatology and his research in skin cancer and innovative medical technologies.
Experience
Dr. Salvador González has an illustrious career spanning over three decades. From 1985 to 1993, he worked as a Clinical Dermatologist for the Penitentiary Health and National Health System in Málaga, Spain. He then pursued significant research in the U.S. as a Beca de Investigación at the Wellman Laboratories of Photomedicine at Massachusetts General Hospital (MGH) from 1993 to 1995. Dr. González’s academic roles include serving as a Dermatology Professor at Harvard Medical School from 1997 to 2000. His academic journey further included being an Assistant Biochemist at MGH, Boston, and an Associate Scientist at Memorial Sloan-Kettering Cancer Center, New York, from 2003 to 2017. He is currently an advisor to the Dermatology Department at Hospital Ramón y Cajal, Madrid, Spain. Dr. González has also held leadership positions in various biopharmaceutical companies, contributing significantly to medical advancements in dermatology, particularly skin cancer and photomedicine.
Awards and Honors
Dr. Salvador González has received numerous prestigious awards and honors throughout his career. In 1999, he was awarded the Alexander A. Fisher Bronze Award by the American Society of Contact Dermatitis. He was named an Honorary Member of the Dermatology Mexican Society and the International Plastic Dermatology Society in 1999 and 2000. He received two Research Awards from The Skin Cancer Foundation in 2000 and 2001. In 2004, Dr. González became an Honorary Member of the Dermatology Academy of Saudi Arabia. His distinguished career has also led to global recognition, including being selected for “Who’s Who” in the USA and being awarded the Melilla’s Year Citizen Award (2005). Notable honors include the 2014 Khosrow Montaz Memorial Lectureship Award from Massachusetts General Hospital, the 2015 Gold Medal from Forum Europe for his contributions to medicine, and the Presidential Citation from the American Academy of Dermatology in 2017 for his work on Reflectance Confocal Microscopy.
Research Focus
Dr. Salvador González’s research focus lies primarily in dermatology, with an emphasis on skin cancer prevention, photodynamic therapy (PDT), and reflectance confocal microscopy. His work has significantly advanced the understanding of basal cell carcinoma, Bowen’s disease, and cutaneous squamous cell carcinoma, particularly in terms of their response to PDT. He has also explored the effects of personalized photoprotection and the impact of blue light on retinal pigment epithelial cells. Dr. González’s research has led to breakthroughs in the clinical application of PDT and new insights into the molecular markers that affect treatment responses. His commitment to advancing non-invasive diagnostic tools, like reflectance confocal microscopy, has revolutionized skin cancer detection. Dr. González continues to lead studies that bridge the gap between basic dermatological science and clinical practice, with a long-term goal of improving patient outcomes and advancing personalized treatments in dermatology.
Publication
- Analysis of Tumoral, Stromal, and Glycolytic Markers in the Response of Basal Cell Carcinoma and Bowen Disease to Photodynamic Therapy in Real Life
- Personalized Photoprotection: Expert Consensus and Recommendations From a Delphi Study Among Dermatologists
- Comparative Response to PDT with Methyl-Aminolevulinate and Temoporfin in Cutaneous and Oral Squamous Cell Carcinoma Cells
- The Effect of Fernblock® in Preventing Blue-Light-Induced Oxidative Stress and Cellular Damage in Retinal Pigment Epithelial Cells
- Application of Dermoscopy and Reflectance Confocal Microscopy in Vivo in the Evaluation of Nevi in Children
- New Trends on Personalized Sunscreens
- Reflectance Confocal Microscopy Terminology in Spanish: A Delphi Consensus Study
- International Expert Recommendations on Image Acquisition for In Vivo Reflectance Confocal Microscopy of Cutaneous Tumors
- The m-TORC1 Inhibitor Sirolimus Increases the Effectiveness of Photodynamic Therapy in the Treatment of Cutaneous Squamous Cell Carcinoma, Impairing NRF2 Antioxidant Signaling
- Conventional PDT Versus One PDT Session Plus 3% Diclofenac Gel for Severe Skin Field Cancerization of the Face and Scalp: Randomized Controlled Trial Assessing Clinical and Histological Response